This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David D. Fulghum, MD; Robert Katz, MD

Arch Dermatol. 1968;98(1):51-52.

Abstract
Five patients with advanced systemic scleroderma were treated with high doses of D-penicillamine for periods up to 11 months. Careful measurement of mobility of involved joints before and after therapy revealed no improvement. Side effects occurred in all patients.

Author Affiliations
Miami, Fla

From the Department of Dermatology, University of Miami School of Medicine, Miami, Fla.

Footnotes
Accepted for publication April 10, 1968.

Reprint requests to Department of Dermatology, University of Miami, Miami, Fla 33152 (Dr. Fulghum).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Penicillamine Dermatopathy With Lymphangiectases: A Clinical, Immunohistologic, and Ultrastructural Study
Goldstein et al.
Arch Dermatol 1989;125:92-97.
ABSTRACT  

D-Penicillamine Therapy in Progressive Systemic Sclerosis (Scleroderma) A Retrospective Analysis
STEEN et al.
ANN INTERN MED 1982;97:652-659.
ABSTRACT